Literature DB >> 30612117

Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts.

Hyon K Choi1,2,3, John H Stone1,3, Zachary S Wallace4,2,3, Yuqing Zhang1,2,3, Cory A Perugino1,3, Ray Naden5.   

Abstract

OBJECTIVE: IgG4-related disease (IgG4-RD) is a heterogeneous, multiorgan condition of unclear aetiology that can cause organ failure. Difficulty recognising IgG4-RD contributes to diagnostic delays. We sought to identify key IgG4-RD phenotypes.
METHODS: We used two cross-sectional studies assembled by an international, multispecialty network of IgG4-RD specialists who submitted 765 cases to derive and replicate phenotypic groups. Phenotype groups of disease manifestations and key covariate distributions across the identified groups were measured using latent class analysis.
RESULTS: In the derivation cohort (n=493), we identified four groups with distinct manifestations: Group 1 (31%), Pancreato-Hepato-Biliary disease; Group 2 (24%), Retroperitoneal Fibrosis and/or Aortitis; Group 3 (24%), Head and Neck-Limited disease and Group 4 (22%), classic Mikulicz syndrome with systemic involvement. We replicated the identification of four phenotype groups in the replication cohort. Compared with cases in Groups 1, 2 and 4, respectively, cases in Group 3 were more likely to be female (OR 11.60 (95% CI 5.39 to 24.98), 10.35 (95% CI 4.63 to 23.15) and 9.24 (95% CI 3.53 to 24.20)) and Asian (OR 6.68 (95% CI 2.82 to 15.79), 7.43 (95% CI 2.97 to 18.56) and 6.27 (95% CI 2.27 to 17.29)). Cases in Group 4 had a higher median serum IgG4 concentration (1170 mg/dL) compared with groups 1-3 (316, 178 and 445 mg/dL, respectively, p<0.001).
CONCLUSION: We identified four distinctive IgG4-RD phenotypes according to organ involvement. Being Asian or female may predispose individuals to head and neck-limited disease. These phenotypes serve as a framework for identifying IgG4-RD and studying its aetiology and optimal treatment. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  IgG4-related disease; cluster analysis; epidemiology

Mesh:

Substances:

Year:  2019        PMID: 30612117      PMCID: PMC6996288          DOI: 10.1136/annrheumdis-2018-214603

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  22 in total

1.  Predictors of disease relapse in IgG4-related disease following rituximab.

Authors:  Zachary S Wallace; Hamid Mattoo; Vinay S Mahajan; Maria Kulikova; Leo Lu; Vikram Deshpande; Hyon K Choi; Shiv Pillai; John H Stone
Journal:  Rheumatology (Oxford)       Date:  2016-02-16       Impact factor: 7.580

2.  PROC LCA: A SAS Procedure for Latent Class Analysis.

Authors:  Stephanie T Lanza; Linda M Collins; David R Lemmon; Joseph L Schafer
Journal:  Struct Equ Modeling       Date:  2007       Impact factor: 6.125

Review 3.  IgG4-related disease.

Authors:  Terumi Kamisawa; Yoh Zen; Shiv Pillai; John H Stone
Journal:  Lancet       Date:  2014-12-04       Impact factor: 79.321

4.  Necessity of early intervention for IgG4-related disease--delayed treatment induces fibrosis progression.

Authors:  Yui Shimizu; Motohisa Yamamoto; Yasuyoshi Naishiro; Gohta Sudoh; Keisuke Ishigami; Hidetaka Yajima; Tetsuya Tabeya; Mikiko Matsui; Chisako Suzuki; Hiroki Takahashi; Nobuhiko Seki; Tetsuo Himi; Ken Yamashita; Hiroko Noguchi; Tadashi Hasegawa; Yasuo Suzuki; Saho Honda; Takashi Abe; Kohzoh Imai; Yasuhisa Shinomura
Journal:  Rheumatology (Oxford)       Date:  2012-12-19       Impact factor: 7.580

5.  Long-term prognosis of autoimmune pancreatitis in terms of glucose tolerance.

Authors:  Kenji Hirano; Akihiro Isogawa; Minoru Tada; Hiroyuki Isayama; Naminatsu Takahara; Koji Miyabayashi; Suguru Mizuno; Dai Mohri; Kazumichi Kawakubo; Takashi Sasaki; Hirofumi Kogure; Natsuyo Yamamoto; Naoki Sasahira; Nobuo Toda; Rie Nagano; Hiroshi Yagioka; Yoko Yashima; Tsuyoshi Hamada; Yukiko Ito; Kazuhiko Koike
Journal:  Pancreas       Date:  2012-07       Impact factor: 3.327

6.  Utility of Serum IgG4 Levels in a Multiethnic Population.

Authors:  Ruyu Qi; Luke Y C Chen; Sujin Park; Robert Irvine; Michael A Seidman; John T Kelsall; David Collins; Vivian Yin; Graham W Slack; Andre Mattman; Eric Lam; Mollie N Carruthers
Journal:  Am J Med Sci       Date:  2017-08-24       Impact factor: 2.378

7.  IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients.

Authors:  Zachary S Wallace; Vikram Deshpande; Hamid Mattoo; Vinay S Mahajan; Maria Kulikova; Shiv Pillai; John H Stone
Journal:  Arthritis Rheumatol       Date:  2015-09       Impact factor: 10.995

8.  Asbestos and smoking as risk factors for idiopathic retroperitoneal fibrosis: a case-control study.

Authors:  Matteo Goldoni; Silvia Bonini; Maria L Urban; Alessandra Palmisano; Giuseppe De Palma; Elisa Galletti; Marco Coggiola; Carlo Buzio; Antonio Mutti; Augusto Vaglio
Journal:  Ann Intern Med       Date:  2014-08-05       Impact factor: 25.391

9.  Are Classification Criteria for IgG4-RD Now Possible? The Concept of IgG4-Related Disease and Proposal of Comprehensive Diagnostic Criteria in Japan.

Authors:  Kazuichi Okazaki; Hisanori Umehara
Journal:  Int J Rheumatol       Date:  2012-05-29

10.  Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis.

Authors:  Phil A Hart; Terumi Kamisawa; William R Brugge; Jae Bock Chung; Emma L Culver; László Czakó; Luca Frulloni; Vay Liang W Go; Thomas M Gress; Myung-Hwan Kim; Shigeyuki Kawa; Kyu Taek Lee; Markus M Lerch; Wei-Chih Liao; Matthias Löhr; Kazuichi Okazaki; Ji Kon Ryu; Nicolas Schleinitz; Kyoko Shimizu; Tooru Shimosegawa; Roy Soetikno; George Webster; Dhiraj Yadav; Yoh Zen; Suresh T Chari
Journal:  Gut       Date:  2012-12-11       Impact factor: 23.059

View more
  53 in total

Review 1.  Vasculitis beyond aortitis in IgG4-related disease (IgG4-RD): case report and review of the literature.

Authors:  George E Fragoulis; Gerasimos Evangelatos; Maria G Tektonidou
Journal:  Clin Rheumatol       Date:  2020-07-24       Impact factor: 2.980

2.  Disease Severity Linked to Increase in Autoantibody Diversity in IgG4-Related Disease.

Authors:  Hang Liu; Cory A Perugino; Musie Ghebremichael; Zachary S Wallace; Sydney B Montesi; John H Stone; Shiv Pillai
Journal:  Arthritis Rheumatol       Date:  2020-02-10       Impact factor: 10.995

Review 3.  Erdheim-Chester disease: a rapidly evolving disease model.

Authors:  Francesco Pegoraro; Matthias Papo; Valerio Maniscalco; Frédéric Charlotte; Julien Haroche; Augusto Vaglio
Journal:  Leukemia       Date:  2020-06-26       Impact factor: 11.528

4.  European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations.

Authors:  J-Matthias Löhr; Ulrich Beuers; Miroslav Vujasinovic; Domenico Alvaro; Jens Brøndum Frøkjær; Frank Buttgereit; Gabriele Capurso; Emma L Culver; Enrique de-Madaria; Emanuel Della-Torre; Sönke Detlefsen; Enrique Dominguez-Muñoz; Piotr Czubkowski; Nils Ewald; Luca Frulloni; Natalya Gubergrits; Deniz Guney Duman; Thilo Hackert; Julio Iglesias-Garcia; Nikolaos Kartalis; Andrea Laghi; Frank Lammert; Fredrik Lindgren; Alexey Okhlobystin; Grzegorz Oracz; Andrea Parniczky; Raffaella Maria Pozzi Mucelli; Vinciane Rebours; Jonas Rosendahl; Nicolas Schleinitz; Alexander Schneider; Eric Fh van Bommel; Caroline Sophie Verbeke; Marie Pierre Vullierme; Heiko Witt
Journal:  United European Gastroenterol J       Date:  2020-06-18       Impact factor: 4.623

Review 5.  IgG4-related hypophysitis.

Authors:  Alireza Amirbaigloo; Fatemeh Esfahanian; Marjan Mouodi; Nasser Rakhshani; Mehdi Zeinalizadeh
Journal:  Endocrine       Date:  2021-04-10       Impact factor: 3.633

6.  Immunoglobulin G and immunoglobulin G subclass concentrations differ according to sex and race.

Authors:  Tyler Harkness; Xiaoqing Fu; Yuqing Zhang; Hyon K Choi; John H Stone; Kimberly G Blumenthal; Zachary S Wallace
Journal:  Ann Allergy Asthma Immunol       Date:  2020-03-27       Impact factor: 6.347

7.  Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related disease.

Authors:  George Goodchild; Rory Jr Peters; Tamsin N Cargill; Harry Martin; Adetokunbo Fadipe; Maria Leandro; Adam Bailey; Jane Collier; Louisa Firmin; Manil Chouhan; Manuel Rodriguez-Justo; Ross Sadler; Roger W Chapman; Helen Bungay; Eve Fryer; Joel David; Raashid Luqmani; Eleanor Barnes; George J Webster; Emma L Culver
Journal:  Clin Med (Lond)       Date:  2020-05       Impact factor: 2.659

Review 8.  Recurrent myelitis and asymptomatic hypophysitis in IgG4-related disease: case-based review.

Authors:  Aigli G Vakrakou; Maria-Eleptheria Evangelopoulos; Georgios Boutzios; Dimitrios Tzanetakos; John Tzartos; Georgios Velonakis; Panagiotis Toulas; Maria Anagnostouli; Elissavet Andreadou; Georgios Koutsis; Leonidas Stefanis; George E Fragoulis; Constantinos Kilidireas
Journal:  Rheumatol Int       Date:  2020-01-02       Impact factor: 2.631

9.  The association of smoking with immunoglobulin G4-related disease: a case-control study.

Authors:  Rachel Wallwork; Cory A Perugino; Xiaoqing Fu; Tyler Harkness; Yuqing Zhang; Hyon K Choi; John H Stone; Zachary S Wallace
Journal:  Rheumatology (Oxford)       Date:  2021-11-03       Impact factor: 7.580

Review 10.  Pericarditis as a manifestation of IgG4-related disease.

Authors:  Michaël Doumen; Bart Vankelecom; René Westhovens; Stijn Michiels
Journal:  Rheumatol Int       Date:  2021-07-13       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.